Insider · CIK 0000315066
Fmr LLC
Files at BEAM (Beam Therapeutics Inc.), SANA (Sana Biotechnology, Inc.), GPCR (Structure Therapeutics Inc.), MTSR (Metsera, Inc.). First filing Jan 10, 2025, latest Sep 4, 2025.
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
BEAM: Beam Therapeutics Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
SANA: Sana Biotechnology, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 32Weak | MTSRsell Metsera, Inc. | $9,648 268 shares | -100% | - | |
| 37Weak | BEAMsell Beam Therapeutics Inc. | $992k 48,374 shares | -2% | +39% from low-41% from high | |
| 37Weak | SANAsell Sana Biotechnology, Inc. | $1.9M 290,912 shares | -6% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 2, 2025 | MTSR Metsera, Inc. | JOther Common Stockindirect: F-Prime Capital Partners Life Sciences Fund VIII LP | -1,350,000 | $0.00 | $0 | 3,189,540 | Sep 4, 2025 |
| Sep 2, 2025 | MTSR Metsera, Inc. | JOther Common Stockindirect: F-Prime Capital Partners Life Sciences Advisors Fund VIII LP | +20,250 | $0.00 | $0 | 20,250 | Sep 4, 2025 |
| Sep 2, 2025 | MTSR Metsera, Inc. | JOther Common Stockindirect: F-Prime Capital Partners Life Sciences Advisors Fund VIII LP | -20,250 | $0.00 | $0 | 0 | Sep 4, 2025 |
| Sep 2, 2025 | MTSR Metsera, Inc. | JOther Common Sharesindirect: F-Prime Inc. | +895 | $0.00 | $0 | 895 | Sep 4, 2025 |
| Sep 2, 2025 | MTSR Metsera, Inc. | JOther Common Stockindirect: Impresa Fund IV LLC | +997,312 | $0.00 | $0 | 997,312 | Sep 4, 2025 |
| Sep 2, 2025 | MTSR Metsera, Inc. | JOther Common Stockindirect: Impresa Fund IV LLC | -997,044 | $0.00 | $0 | 268 | Sep 4, 2025 |
| Sep 2, 2025 | MTSR Metsera, Inc. | SOpen-market sale Common Stockindirect: Impresa Fund IV LLC | -268 | $36.00 | $9,648 | 0 | Sep 4, 2025 |
| Sep 2, 2025 | MTSR Metsera, Inc. | JOther Common Stockindirect: Shares held by persons and entities whose shares are subject to reporting by the undersigned. | +1,134,258 | $0.00 | $0 | 1,134,258 | Sep 4, 2025 |
| Jul 30, 2025 | GPCR Structure Therapeutics Inc. | SOpen-market sale American Depositary Sharesderivativeindirect: Shares held by persons and entities whose shares are subject to reporting by the undersigned | -26,310 | $17.87 | $470k | 1,515,558 | Aug 1, 2025 |
| Jul 30, 2025 | BEAM Beam Therapeutics Inc. | SOpen-market sale Common Stockindirect: Shares held by persons and entities whose shares are subject to reporting by the undersigned. | -48,374 | $20.50 | $992k | 2,073,665 | Aug 1, 2025 |
| Feb 6, 2025 | GPCR Structure Therapeutics Inc. | SOpen-market sale American Depositary Sharesderivativeindirect: FIMM, LLC | -41 | $30.54 | $1,252 | 0 | Feb 10, 2025 |
| Feb 3, 2025 | MTSR Metsera, Inc. | CConversion Common Stockindirect: F-Prime Capital Partners Life Sciences Fund VIII LP | +1,418,606 | - | - | 1,418,606 | Feb 5, 2025 |
| Feb 3, 2025 | MTSR Metsera, Inc. | CConversion Common Stockindirect: F-Prime Capital Partners Life Sciences Fund VIII LP | +3,120,934 | - | - | 4,539,540 | Feb 5, 2025 |
| Feb 3, 2025 | MTSR Metsera, Inc. | CConversion Series Seed Preferred Stockderivativeindirect: F-Prime Capital Partners Life Sciences Fund VIII LP | -1,418,606 | - | - | 0 | Feb 5, 2025 |
| Feb 3, 2025 | MTSR Metsera, Inc. | CConversion Series A Preferred Stockderivativeindirect: F-Prime Capital Partners Life Sciences Fund VIII LP | -3,120,934 | - | - | 0 | Feb 5, 2025 |
| Jan 8, 2025 | SANA Sana Biotechnology, Inc. | SOpen-market sale Common Stockindirect: F-Prime Capital Partners Life Sciences Fund VI LP | -100,000 | $6.11 | $611k | 4,732,423 | Jan 10, 2025 |
| Jan 8, 2025 | SANA Sana Biotechnology, Inc. | SOpen-market sale Common Stockindirect: F-Prime Capital Partners Life Sciences Fund VI LP | -25,000 | $6.50 | $163k | 4,707,423 | Jan 10, 2025 |
| Jan 8, 2025 | SANA Sana Biotechnology, Inc. | SOpen-market sale Common Stockindirect: F-Prime Capital Partners Life Sciences Fund VI LP | -164,912 | $6.71 | $1.1M | 4,542,511 | Jan 10, 2025 |
| Jan 8, 2025 | SANA Sana Biotechnology, Inc. | SOpen-market sale Common Stockindirect: F-Prime Capital Partners Life Sciences Fund VI LP | -1,000 | $7.26 | $7,260 | 4,541,511 | Jan 10, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.